Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1984 Mar;59(3):256–259. doi: 10.1136/adc.59.3.256

Amoxycillin and clavulanic acid in the treatment of urinary infection.

L G Al Roomi, A M Sutton, F Cockburn, T A McAllister
PMCID: PMC1628547  PMID: 6712275

Abstract

The pharmacokinetics and clinical efficacy of amoxycillin combined with clavulanic acid in the treatment of 32 children with urinary tract infection were studied. Twenty one (80%) of 26 children with proved urinary tract infection showed a favourable clinical and bacteriological response. Fifteen of these children had amoxycillin resistant organisms and were treated successfully. In 20 children the serum and urine concentrations of amoxycillin and clavulanic acid were measured after the first oral dose.

Full text

PDF
256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball A. P., Geddes A. M., Davey P. G., Farrell I. D., Brookes G. R. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study. Lancet. 1980 Mar 22;1(8169):620–623. doi: 10.1016/s0140-6736(80)91118-6. [DOI] [PubMed] [Google Scholar]
  2. Bass J. W., Crowley D. M., Steele R. W., Young F. S., Harden L. B. Adverse effects of orally administered ampicillin. J Pediatr. 1973 Jul;83(1):106–108. doi: 10.1016/s0022-3476(73)80328-2. [DOI] [PubMed] [Google Scholar]
  3. Boothman R., Laidlaw M., Richards I. D. Prevalence of urinary tract infection in children of preschool age. Arch Dis Child. 1974 Dec;49(12):917–922. doi: 10.1136/adc.49.12.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crump J., Cansdale S. Enterobacter resistant to amoxycillin/clavulanate. Lancet. 1982 Aug 28;2(8296):500–500. doi: 10.1016/s0140-6736(82)90531-1. [DOI] [PubMed] [Google Scholar]
  5. Fast M. V., Nsanze H., D'Costa L. J., Plummer F. A., Karasira P., Maclean I. W., Ronald A. R. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection. Lancet. 1982 Sep 4;2(8297):509–511. doi: 10.1016/s0140-6736(82)90597-9. [DOI] [PubMed] [Google Scholar]
  6. McAllister T. A. Penicillins in perspective. Scott Med J. 1982;27(Spec No):S39–S47. doi: 10.1177/00369330820270S109. [DOI] [PubMed] [Google Scholar]
  7. Reading C., Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. doi: 10.1128/aac.11.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sykes R. B., Matthew M. The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother. 1976 Jun;2(2):115–157. doi: 10.1093/jac/2.2.115. [DOI] [PubMed] [Google Scholar]
  9. Wise P. J., Neu H. C. Experience with amoxicillin: an overall summary of clinical trials in the United States. J Infect Dis. 1974 Jun;129(0):suppl–suppl:S271. doi: 10.1093/infdis/129.supplement_2.s266. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES